119 related articles for article (PubMed ID: 1701816)
21. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.
Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC
Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of the opsonic capacity of core lipopolysaccharide antiserum of equine origin against smooth Escherichia coli 0111:B4, using macrophage chemiluminescence.
Morris DD; Harmon BG; Moore JN
Am J Vet Res; 1989 Aug; 50(8):1272-8. PubMed ID: 2675693
[TBL] [Abstract][Full Text] [Related]
23. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
[TBL] [Abstract][Full Text] [Related]
24. Influence of subinhibitory levels of antibiotics on expression of Escherichia coli lipopolysaccharide and binding of anti-lipopolysaccharide monoclonal antibodies.
Nelson D; Delahooke TE; Poxton IR
J Med Microbiol; 1993 Aug; 39(2):100-6. PubMed ID: 8345504
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies reactive with K1-encapsulated Escherichia coli lipopolysaccharide are opsonic and protect mice against lethal challenge.
Kaufman BM; Cross AS; Futrovsky SL; Sidberry HF; Sadoff JC
Infect Immun; 1986 May; 52(2):617-9. PubMed ID: 3516883
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of intramammary immunization with an Escherichia coli J5 bacterin.
Smith JL; Hogan JS; Smith KL
J Dairy Sci; 1999 Dec; 82(12):2582-8. PubMed ID: 10629804
[TBL] [Abstract][Full Text] [Related]
27. Protective features of monoclonal antibodies to Escherichia coli during experimental infection of mice with homologous and heterologous serotypes of E. coli.
Raponi G; Ghezzi MC; Lun MT; Bigotti G; Natali PG; Mancini C
J Med Microbiol; 2000 Mar; 49(3):253-260. PubMed ID: 10707945
[TBL] [Abstract][Full Text] [Related]
28. The effect of splenectomy on antibody response to lipopolysaccharide (E. coli) immunization.
Ohshio G; Manabe T; Tobe T; Khine M; Hamashima Y
J Trauma; 1988 Mar; 28(3):379-82. PubMed ID: 3127597
[TBL] [Abstract][Full Text] [Related]
29. Bactericidal and opsonic activities of normal sheep serum against gram-negative bacteria.
Mittal KR; Ingram DG
Am J Vet Res; 1975 Aug; 36(08):1189-93. PubMed ID: 1098532
[TBL] [Abstract][Full Text] [Related]
30. Enhanced protection by use of a combination of anticapsule and antilipopolysaccharide monoclonal antibodies against lethal Escherichia coli O18K5 infection of mice.
Frasa H; Benaissa-Trouw B; Tavares L; van Kessel K; Poppelier M; Kraaijeveld K; Verhoef J
Infect Immun; 1996 Mar; 64(3):775-81. PubMed ID: 8641781
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of immunization with ferric citrate receptor FecA from Escherichia coli on induced coliform mastitis.
Takemura K; Hogan JS; Lin J; Smith KL
J Dairy Sci; 2002 Apr; 85(4):774-81. PubMed ID: 12018422
[TBL] [Abstract][Full Text] [Related]
32. Intramammary immunization with ultraviolet-killed Escherichia coli shows partial protection against late gestation intramammary challenge with a homologous strain.
Pomeroy B; Gurjar A; Sipka A; Klaessig S; Salmon S; Quesnell R; Schukken YH
J Dairy Sci; 2016 Nov; 99(11):9014-9026. PubMed ID: 27638260
[TBL] [Abstract][Full Text] [Related]
33. Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains.
Pecha B; Low D; O'Hanley P
J Clin Invest; 1989 Jun; 83(6):2102-8. PubMed ID: 2566625
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
Baumgartner JD; Heumann D; Calandra T; Glauser MP
J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
[TBL] [Abstract][Full Text] [Related]
35. Resistance of broiler chickens to Escherichia coli respiratory tract infection induced by passively transferred egg-yolk antibodies.
Kariyawasam S; Wilkie BN; Gyles CL
Vet Microbiol; 2004 Mar; 98(3-4):273-84. PubMed ID: 15036536
[TBL] [Abstract][Full Text] [Related]
36. Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice.
Tobias J; Svennerholm AM; Carlin NI; Lebens M; Holmgren J
Vaccine; 2011 Nov; 29(48):8863-9. PubMed ID: 21983363
[TBL] [Abstract][Full Text] [Related]
37. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
Dunn DL; Mach PA; Condie RM; Cerra FB
Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
[TBL] [Abstract][Full Text] [Related]
38. Antibodies to core lipopolysaccharide determinants: absence of cross-reactivity with heterologous lipopolysaccharides.
Heumann D; Baumgartner JD; Jacot-Guillarmod H; Glauser MP
J Infect Dis; 1991 Apr; 163(4):762-8. PubMed ID: 1707084
[TBL] [Abstract][Full Text] [Related]
39. An enzyme-linked immunosorbent assay for detection of antibodies against Escherichia coli: association between indirect hemagglutination test and survival.
Leitner G; Melamed D; Drabkin N; Heller ED
Avian Dis; 1990; 34(1):58-62. PubMed ID: 2181997
[TBL] [Abstract][Full Text] [Related]
40. Administration in vivo of recombinant interleukin 2 protects mice against septic death.
Weyand C; Goronzy J; Fathman CG; O'Hanley P
J Clin Invest; 1987 Jun; 79(6):1756-63. PubMed ID: 3294901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
